INSOMNIA is the #4 most commonly reported adverse reaction for QUETIAPINE, manufactured by H2-Pharma, LLC. There are 9,101 FDA adverse event reports linking QUETIAPINE to INSOMNIA. This represents approximately 2.1% of all 427,224 adverse event reports for this drug.
QUETIAPINE has an overall safety score of 85 out of 100. Patients taking QUETIAPINE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA9,101 of 427,224 reports
INSOMNIA is a less commonly reported adverse event for QUETIAPINE, but still significant enough to appear in the safety profile.
Other Side Effects of QUETIAPINE
In addition to insomnia, the following adverse reactions have been reported for QUETIAPINE:
INSOMNIA has been reported as an adverse event in 9,101 FDA reports for QUETIAPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with QUETIAPINE?
INSOMNIA accounts for approximately 2.1% of all adverse event reports for QUETIAPINE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking QUETIAPINE?
If you experience insomnia while taking QUETIAPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.